| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | APOBR | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | HNRNPLL | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | HRASLS | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | DUSP9 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ITPK1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SECISBP2L | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | TMEM177 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | LRRC7 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ADGRF3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PLCXD3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
